Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wang Xiaodong −$46.8M Director sold 100% of stake
  2. Lee Chan Henry −$865K SVP, General Counsel sold 100% of stake
  3. Ball Titus B. −$679K Principal Accounting Officer sold 100% of stake
  4. Wu Xiaobin −$106K President and COO sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-08-31 OYLER JOHN Chief Executive Officer Sale −5,707 $241.14 $1.4M 3,354
2020-08-31 OYLER JOHN Chief Executive Officer Sale −3,312 $242.15 $802K 42
2020-08-31 OYLER JOHN Chief Executive Officer Sale −42 $242.81 $10K 0
2020-08-28 Huang Jane CMO, Hematology Option exercise +3,000 $29.49 $88K 3,000
2020-08-28 Huang Jane CMO, Hematology Sale −800 $240.15 $192K 2,200
2020-08-28 Huang Jane CMO, Hematology Sale −200 $240.86 $48K 2,000
2020-08-28 Huang Jane CMO, Hematology Sale −1,000 $242.41 $242K 1,000
2020-08-28 Huang Jane CMO, Hematology Sale −700 $243.49 $170K 300
2020-08-28 Huang Jane CMO, Hematology Sale −300 $244.93 $73K 0
2020-08-28 Huang Jane CMO, Hematology Option exercise · Share Option (Right to Buy) −39,000 402,575
2020-08-25 AMGEN INC 10% owner Grant or award +59,390 $248.49 $14.8M 18,524,373
2020-08-24 Sanders Corazon (Corsee) D. Director Grant or award · Share Option (Right to Buy) +27,482 27,482
2020-08-24 AMGEN INC 10% owner Grant or award +59,390 $239.10 $14.2M 18,464,983
2020-08-21 AMGEN INC 10% owner Grant or award +64,176 $230.18 $14.8M 18,405,593
2020-08-21 OYLER JOHN Chief Executive Officer Sale −3,103 $237.80 $738K 37,685
2020-08-21 OYLER JOHN Chief Executive Officer Sale −10,568 $238.86 $2.5M 27,117
2020-08-21 OYLER JOHN Chief Executive Officer Sale −10,997 $239.66 $2.6M 16,120
2020-08-21 OYLER JOHN Chief Executive Officer Sale −6,255 $240.64 $1.5M 9,865
2020-08-21 OYLER JOHN Chief Executive Officer Sale −2,471 $241.62 $597K 7,394
2020-08-21 OYLER JOHN Chief Executive Officer Sale −6,700 $242.96 $1.6M 694

Page 82 of 99 · 1,972 trades